Health Services Research Department, Institute of Psychiatry, Kings College London, UK
Department of Psychiatry II, University of Ulm, BKH Günzburg, Germany
Department of Medicine and Public Health, Policlinico G.B. Rossi, Verona, Italy
Section of Cognitive Neuropsychiatry
Health Services Research Department, Institute of Psychiatry, Kings College London, UK
Academic Medical Center, Department of Psychiatry, University of Amsterdam, The Netherlands
Department of Psychiatry II, University of Ulm, BKH Günzburg, Germany
Academic Medical Center, Department of Psychiatry, University of Amsterdam, The Netherlands
Health Services Research Department, Institute of Psychiatry, Kings College London, UK
Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Italy.
Correspondence: Dr Richard Gray, Health Services Department, Institute of Psychiatry, Kings College London, De Crespigny Park, London SE5 8AF, UK.Tel.: +444 (0)20 7848 0139; fax: +44 (0)20 7848 0458; email: R.Gray{at}iop.kcl.ac.uk
Declaration of interest None. Funding detailed in Acknowledgements.
Background There is equivocal evidence of the effectiveness of adherence therapy in improving treatment adherence and clinical outcomes for people with schizophrenia.
Aims To evaluate the effectiveness of adherence therapy in improving quality of life for people with schizophrenia.
Method A 52-week, single-blind, multicentre randomised controlled trial of the effectiveness of adherence therapy. Participants were individually randomised to receive eight sessions of adherence therapy or health education. Assessments were undertaken at baseline and at 52-week follow-up.
Results Adherence therapy was no more effective than health education in improving quality of life.
Conclusions This effectiveness trial provides evidence for the lack of effect of adherence therapy in people with schizophrenia with recent clinical instability, treated in ordinary clinical settings.
This article has been cited by other articles:
![]() |
R. Gray, R. Spilling, D. Burgess, and T. Newey Antipsychotic long-acting injections in clinical practice: medication management and patient choice The British Journal of Psychiatry, November 1, 2009; 195(52): S51 - S56. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Byerly and P. Nakonezny Adherence therapy does not improve quality of life in people with schizophrenia Evid. Based Ment. Health, August 1, 2007; 10(3): 75 - 75. [Full Text] [PDF] |
||||
Read all eLetters